Love Pharma Inc.: Love Pharma Investee, Starton Therapeutics, Strengthens Board With New Member

Please see the previously announced news from Starton Therapeutics Inc.VANCOUVER, BC / ACCESSWIRE / November 2, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company")(CSE:LUV)(FSE:G1Q0), is please to announce

Related Keywords

Sao Paulo ,Sãpaulo ,Brazil ,New York ,United States ,United Kingdom ,Bolivia ,Vancouver ,British Columbia ,Canada ,Florida ,Mexico City ,Distrito Federal ,Mexico ,Portugal ,Colombia ,Guatemala ,Dominican Republic ,Ecuador ,Italy ,Chile ,Espirito Santo ,Durango ,Panama ,Spain ,France ,Italian ,America ,Canadian ,Spanish ,French ,Portuguese ,American ,Pedro Lichtinger ,Zachary Stadnyk ,Armando Alvares Penteado ,Cidnee Vaykovich ,Espirito Santo Investment Bank ,Starton Therapeutics Inc ,Haitong Bank ,Westlb Bank ,Neither The Canadian Securities Exchange ,Love Pharma Inc ,Business Administration ,Love Pharma Inc View ,Canadian Securities Exchange ,Pharma Co ,Regulation Services Provider ,Starton Therapeutics ,Moses Dodo ,Independent Director Moses ,Bupa Global ,General Manager ,Central America ,Amedex Bermuda ,Life Insurance ,Hth Geoblue ,Blue Cross Shield ,Senior Managing Director ,North American ,Divisional Board ,Latin America ,Starton Therapeutic Chief Operating Officer ,Love Pharma ,Private Securities Litigation Reform Act ,Love ,Dharma ,Investee ,Tarton ,Herapeutics ,Trengthens ,Board ,Ith ,Member ,